Ruchi Bansal

4.1k total citations
85 papers, 3.1k citations indexed

About

Ruchi Bansal is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ruchi Bansal has authored 85 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 29 papers in Hepatology and 18 papers in Surgery. Recurrent topics in Ruchi Bansal's work include Liver physiology and pathology (27 papers), Liver Disease Diagnosis and Treatment (26 papers) and Phagocytosis and Immune Regulation (8 papers). Ruchi Bansal is often cited by papers focused on Liver physiology and pathology (27 papers), Liver Disease Diagnosis and Treatment (26 papers) and Phagocytosis and Immune Regulation (8 papers). Ruchi Bansal collaborates with scholars based in Netherlands, United States and Germany. Ruchi Bansal's co-authors include Jai Prakash, Gert Storm, Jonas Schnittert, Ralf Weiskirchen, Klaas Poelstra, D. van der Heide, Saleh Yazdani, Twan Lammers, Deby Fajar Mardhian and Yu Shrike Zhang and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ruchi Bansal

81 papers receiving 3.1k citations

Peers

Countries citing papers authored by Ruchi Bansal

Since Specialization

Citations

This map shows the geographic impact of Ruchi Bansal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruchi Bansal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruchi Bansal more than expected).

Fields of papers citing papers by Ruchi Bansal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruchi Bansal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruchi Bansal. The network helps show where Ruchi Bansal may publish in the future.

Co-authorship network of co-authors of Ruchi Bansal

This figure shows the co-authorship network connecting the top 25 collaborators of Ruchi Bansal. A scholar is included among the top collaborators of Ruchi Bansal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruchi Bansal. Ruchi Bansal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients 2025 ·Cancer Research Communications ·(unknown), (unknown), Michiel Stevens, (unknown), (unknown), (unknown), John W.M. Martens, Jaco Kraan, Nick Beije, Martijn P. Lolkema, Peter A.W. te Boekhorst, Paul Hamberg, Brigitte C.M. Haberkorn, Danny Houtsma, (unknown), Wendy M. van der Deure, Ruchi Bansal, Leon W.M.M. Terstappen	0
2	Secretome Analysis of Prostate Cancer Cell Lines Reveals Cell Cycle-Dependent PSA Secretion and Potential Biomarkers 2025 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Jaco Kraan, Leon W.M.M. Terstappen, Ruchi Bansal	1
3	Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients 2024 ·Molecular Oncology ·(unknown), Leon W.M.M. Terstappen, (unknown), (unknown), Jaco Kraan, John W.M. Martens, Ruchi Bansal	7
4	Inhibition of intrahepatic monocyte recruitment by Cenicriviroc and extracellular matrix degradation by MMP1 synergistically attenuate liver inflammation and fibrogenesis in vivo 2024 ·Scientific Reports ·(unknown), (unknown), Ruchi Bansal	5
5	Implications of innate immune sexual dimorphism for MASLD pathogenesis and treatment 2024 ·Trends in Pharmacological Sciences ·(unknown), Prakash Ramachandran, Ruchi Bansal	13
6	The Material World of 3D‐Bioprinted and Microfluidic‐Chip Models of Human Liver Fibrosis 2023 ·Advanced Materials ·(unknown), Ruchi Bansal, Cristina C. Barrias, Bruno Sarmento	20
7	Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients 2022 ·Cancers ·(unknown), (unknown), (unknown), Afroditi Nanou, (unknown), Frank Coumans, Leon W.M.M. Terstappen, Jaco Kraan, John W.M. Martens, Ruchi Bansal, Martijn P. Lolkema	7
8	Lipoxygenases in chronic liver diseases: current insights and future perspectives 2021 ·Trends in Pharmacological Sciences ·(unknown), (unknown), Amit Khurana, Ralf Weiskirchen, Ruchi Bansal	9
9	Immune Organs and Immune Cells on a Chip: An Overview of Biomedical Applications 2020 ·Micromachines ·Margaretha Morsink, Niels Willemen, Jeroen Leijten, Ruchi Bansal, Su Ryon Shin	51
10	Apoptosis-inducing peptide loaded in PLGA nanoparticles induces anti-tumor effects in vivo 2020 ·International Journal of Pharmaceutics ·(unknown), (unknown), Ruchi Bansal, Sima Rahimian, Gert Storm, Wim E. Hennink, Jai Prakash	16
11	3D‐Bioprinted Mini‐Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics 2019 ·Advanced Materials ·Marcel Alexander Heinrich, Ruchi Bansal, Twan Lammers, Yu Shrike Zhang, Raymond M. Schiffelers, Jai Prakash	244
12	ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer 2019 ·Science Advances ·Praneeth R. Kuninty, Ruchi Bansal, Susanna W.L. de Geus, Deby Fajar Mardhian, Jonas Schnittert, Joop van Baarlen, Gert Storm, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven, Josbert M. Metselaar, Peter J.K. Kuppen, Alexander L. Vahrmeijer, Arne Östman, Cornelis F.M. Sier, Jai Prakash	97
13	Targeting Pancreatic Stellate Cells in Cancer 2019 ·Trends in cancer ·Jonas Schnittert, Ruchi Bansal, Jai Prakash	110
14	Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo 2018 ·Journal of Controlled Release ·Deby Fajar Mardhian, Gert Storm, Ruchi Bansal, Jai Prakash	93
15	Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases 2017 ·Experimental & Molecular Medicine ·Ruchi Bansal, Shigeki Nakagawa, Saleh Yazdani, Joop van Baarlen, Anu Venkatesh, Anna P. Koh, Won‐Min Song, Nicolas Goossens, Hideo Watanabe, Mary Beth Beasley, Charles A. Powell, Gert Storm, Naftali Kaminski, Harry van Goor, Scott L. Friedman, Yujin Hoshida, Jai Prakash	59
16	Drug targeting to myofibroblasts: Implications for fibrosis and cancer 2017 ·Advanced Drug Delivery Reviews ·Saleh Yazdani, Ruchi Bansal, Jai Prakash	148
17	Selective delivery of IFN‐γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis 2014 ·The FASEB Journal ·(unknown), Ruchi Bansal, Saleh Yazdani, Jai Prakash, Eduard Post, Pieter A. Klok, Jacob van den Born, Martin H. de Borst, Harry van Goor, Klaas Poelstra, Jan‐Luuk Hillebrands	61
18	A Case of West Nile Poliomyelitis 2014 ·CHEST Journal ·(unknown), Ruchi Bansal, (unknown), (unknown)	1
19	Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth 2012 ·Molecular Cancer Therapeutics ·Ruchi Bansal, Tushar Tomar, Arne Östman, Klaas Poelstra, Jai Prakash	39
20	New validated RP-UPLC method for determination of aripiprazole assay in aripiprazole tablets 2011 ·Latin American Journal of Pharmacy ·(unknown), Ruchi Bansal, Dhirendra Singh, Lokesh Kumar Singh	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact